SKI Market

A+| A| A-|

Indian Indices

Sensex

75,221.69 -1,482.44
( -1.93%)

Global Indices

Nasdaq

46,241.86 -772.41
(-1.64%)

Dow Jones

6,644.85 -92.24
(-1.37%)

Hang Seng

55,100.12 1,399.73
(2.61%)

Nikkei 225

10,289.25 -114.35
(-1.10%)

Forex

USD-INR

92.39 0.06
(0.06%)

EUR-INR

106.38 0.46
(0.44%)

GBP-INR

123.15 0.52
(0.42%)

JPY-INR

0.58 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5552288

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

22.36

102442.75

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.26

Back

muk& engineers ltdmerged

Wendt India consolidated net profit declines 63.75% in the December 2025 quarter

Jan 21,2026

Net profit of Wendt India declined 63.75% to Rs 2.98 crore in the quarter ended December 2025 as against Rs 8.22 crore during the previous quarter ended December 2024. Sales rose 14.52% to Rs 60.32 crore in the quarter ended December 2025 as against Rs 52.67 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	60.32	52.67	15
OPM %	12.14	20.92	-
PBDT	8.67	12.93	-33
PBT	5.04	10.62	-53
NP	2.98	8.22	-64

75,221.69 -1,482.44 ( -1.93%)

46,241.86 -772.41 (-1.64%)

6,644.85 -92.24 (-1.37%)

55,100.12 1,399.73 (2.61%)

10,289.25 -114.35 (-1.10%)

92.39 0.06 (0.06%)

106.38 0.46 (0.44%)

123.15 0.52 (0.42%)

0.58 0.00 (0.14%)